SymbolHBIO
NameHARVARD BIOSCIENCE INC
SectorINDUSTRIALS
RegionNorth America
IndustryLaboratory Analytical Instruments
Address84 OCTOBER HILL RD, HOLLISTON, MA 01746
Telephone5088938999
Fax
Email
Websitehttps://www.harvardbioscience.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001123494
Description

Harvard Bioscience Inc is a US-based developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States.

Additional info from NASDAQ:
Harvard Bioscience Inc is a US-based developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States.

2026-06-12 15:52

Director Eade Katherine A. 🟢 acquired 16.6K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Jun 09, 2026 | Filing ID: 004082

Read more
2026-06-11 16:56

Director Snider William 🟢 acquired 16.6K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Jun 09, 2026 | Filing ID: 004060

Read more
2026-06-11 14:03

Director DENELSKY STEPHEN J 🟢 acquired 16.6K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Jun 09, 2026 | Filing ID: 004058

Read more
2026-06-11 14:02

Director Gagnon Robert E. 🟢 acquired 16.6K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Jun 09, 2026 | Filing ID: 004057

Read more
2026-06-11 14:00

Director Benson Seth Benjamin 🟢 acquired 16.6K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Jun 09, 2026 | Filing ID: 004056

Read more
2026-06-10 17:11

New Form S-8 - HARVARD BIOSCIENCE INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001171843-26-004037 <b>Size:</b> 213 KB

Read more
2026-06-02 20:01

(99% Neutral) HARVARD BIOSCIENCE INC (HBIO) Announces Executive Changes

Read more
2026-05-27 08:30

New Form SD - HARVARD BIOSCIENCE INC <b>Filed:</b> 2026-05-27 <b>AccNo:</b> 0001171843-26-003718 <b>Size:</b> 35 KB

Read more
2026-05-14 14:09

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0001019432-26-000010 <b>Size:</b> 6 KB

Read more
2026-05-12 11:30

(19% Negative) HARVARD BIOSCIENCE INC (HBIO) Files Form 8-K

Read more